Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
Screen a stock
TERMINAL
IR

IRIXStock

NASDAQ NMS - GLOBAL MARKET · Healthcare · US

$0.445 last close 2026-11-20
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment IRIX's does — no target price to set, unlike a price alert.

Stable Ratio screen, 5 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Listing Nasdaq has marked this issuer deficient against its continued-listing rules. A listing-standards matter, not a Sharia one, and not our assessment — it is the exchange's, from its published symbol directory.
Sharia status
COMPLIANT
Per our in-house ratio engine
5 of 7 pass our own screen — the standards disagree
Purification 100.00% *HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🔴 AVOID
The main driver: lagging the market by 34.7%. Too many signals pointing the wrong way. Wait for the picture to...
Scores: 1 bullish / 3 bearish
35
of 100
Setup confidence — system conviction, not win probabilityD

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 4 timeframes bullish · 88.2% aligned
VWAPPrice below VWAP ($0.51)
VolumeRelative volume 13.9× the 20-day average
Momentum10-day rate of change -32.3%
Overall readAVOID

IRIX is currently considered halal (Sharia-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Price target
$2.00
+349.5% · 1 analysts
Institutional own.
17.1%
of shares
Momentum (10d)
-32.3%
rate of change
SMC grade
D · 35
88.2% aligned
100.00% *
Purification ratio (secondary provider, uncertain)
<0.01%
Non-permissible income — HTR, from filings (2026-10-03)
D · 35
SMC grade — 88.2% timeframe alignment
-32.3%
Rate of change (10d)
$2.00
Price target (+349.5%) · 1 analysts
17.1%
Institutional ownership

How the status reached this point

Compliant since Nov 19, 2026

First seen by our daily status check on Nov 19, 2026; it read Not rated on Nov 18, 2026, so the change landed between those two checks.

$0.5 — last close we recorded while it was still Not rated, Nov 18, 2026

  • Nov 19, 2026 Not rated → Compliant5 of 7 decided standards pass; AAOIFI debt ratio 87.2%; figures as of Oct 3, 2026
  • Nov 17, 2026 Tracking began Nothing before this date is on record.

Read once a day from the status this page publishes, last on Nov 21, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-10-03. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $8.5M as of 2026-11-19.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail 1 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 87.23% 30.00% Fail(57.2pp over)
Interest-bearing investments 43.10% 30.00% Fail(13.1pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Usmani Pass 5 of 5 ratios pass
RatioValueThresholdResult
Interest-bearing debt 25.40% 33.00% Pass(7.6pp buffer)
Interest-bearing investments 12.55% 33.00% Pass(20.5pp buffer)
Non-liquid assets 73.11% at least 20.00% Pass(53.1pp above the floor)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Net liquid assets per share $-5.1M under mkt cap $8.5M Pass
MSCI Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 25.40% 33.33% Pass(7.9pp buffer)
Cash + interest-bearing securities 12.55% 33.33% Pass(20.8pp buffer)
Accounts receivable 26.89% 33.33% Pass(6.4pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
FTSE Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 13.07% 33.33% Pass(20.3pp buffer)
Cash + interest-bearing securities 12.55% 33.33% Pass(20.8pp buffer)
Accounts receivable 26.89% 50.00% Pass(23.1pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Dow Jones Islamic Market Fail 3 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 34.59% 33.00% Fail(1.6pp over)
Cash + interest-bearing securities 17.09% 33.00% Pass(15.9pp buffer)
Accounts receivable 19.53% 33.00% Pass(13.5pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 26.12% 33.00% Pass(6.9pp buffer)
Cash + interest-bearing securities 12.91% 49.00% Pass(36.1pp buffer)
Accounts receivable 14.75% 49.00% Pass(34.2pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 26.12% 33.33% Pass(7.2pp buffer)
Cash + interest-bearing securities 12.91% 33.33% Pass(20.4pp buffer)
Accounts receivable 27.66% 49.00% Pass(21.3pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
Usmani (% of total assets)non permissible income ratio 5.0pts
Dow Jones Islamic Market (% of 24-mo avg market cap)non permissible income ratio 5.0pts
AAOIFI Standard 21 (% of market cap)debt ratio 57.2pts
AAOIFI Standard 21 (% of market cap)investments ratio 13.1pts
Dow Jones Islamic Market (% of 24-mo avg market cap)debt ratio 1.6pts

The numbers the ratios are built from

Read from IRIX's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $52.7M 2026-10-03 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $3.8M 2026-10-03 ConvertibleLongTermNotesPayable
Cash and interest-bearing securitiesCash, equivalents and marketable securities $3.7M 2026-10-03 CashAndCashEquivalentsAtCarryingValue
Total assetsBalance sheet total $29.3M 2026-10-03 Assets
Market capDenominator for AAOIFI $8.5M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $25.7M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $19.4M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-10-03 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-17, period ended 2026-10-03. Income statement: Annual report (10-K) filed 2026-04-02, period ended 2026-10-03. Screened 2026-11-19.

  • Total assets$29.3M
    Assets · period ended 2026-10-03 · 10-Q filed 2026-11-17
  • Interest-bearing debt$3.8M
    ConvertibleLongTermNotesPayable · period ended 2026-10-03 · 10-Q filed 2026-11-17
  • Cash and interest-bearing securities$3.7M
    CashAndCashEquivalentsAtCarryingValue · period ended 2026-10-03 · 10-Q filed 2026-11-17
  • Receivables$4.2M
    AccountsReceivableNetCurrent · period ended 2026-10-03 · 10-Q filed 2026-11-17
  • Revenue$52.7M
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2026-01-03 · 10-K filed 2026-04-02
  • Interest income (non-permissible)$0
    no interest-income tag reported in 3+ years (treated as $0) · income statement as of 2026-10-03 · no filing link for this figure
  • Market cap$8.5M
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-19 · not a filing figure, so no link

5 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for IRIX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-19 Fail → Pass filing re-screen
  • 2026-11-19 Unverified → Fail filing re-screen
  • 2026-11-19 Unverified → Pass filing re-screen

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 5 pass and 2 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-10-03; market cap as stored on 2026-11-19.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's debt ratio is $7.4M debt (operating leases included, as the screen counts it) over a market cap of $8.5M (as of 2026-11-19), 87.2% against a 30% line.

It would pass if the market cap rose above $24.8M (+191%), about $1.39 a share against $0.48 implied by the screen's own figures.

AAOIFI would then pass; the majority verdict would stay Compliant (6 of 7 decided standards passing).

AAOIFI's investments ratio is $3.7M cash and interest-bearing investments over a market cap of $8.5M (as of 2026-11-19), 43.1% against a 30% line.

It would pass if the market cap rose above $12.2M (+44%), about $0.69 a share against $0.48 implied by the screen's own figures.

AAOIFI would then fail; the majority verdict would stay Compliant (5 of 7 decided standards passing).

At the screen's market cap, it would take $1.1M less cash and interest-bearing investments to clear the line.

AAOIFI would then fail; the majority verdict would stay Compliant (5 of 7 decided standards passing, counting every standard that divides the same figure).

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Medical Devices listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
ABTAbbott Laboratories $201.9B —
SYKStryker Corp. $125.7B —
MDTMedtronic Plc $117.8B —
BSXBoston Scientific Corp. $71.0B —
EWEdwards Lifesciences Corp $52.2B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold IRIX

1 of the 202 funds whose filed holdings we currently hold own IRIX shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns IRIX.

You may already own it

Widely held U.S. index funds. If you own one, you own IRIX through it. None of them is a Shariah fund; the last column is our look-through of each.

FundIRIX in fundFund compliant by weight
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.00% 54%

Sorted by IRIX’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names IRIX once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding IRIX
InvestorFirmPositionWeightAs of
Peter Brown Renaissance Technologies $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

1.561.281.000.720.442025-11-242026-05-272026-11-20

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
0.40
S2
0.42
S1
0.45
PIVOT
0.47
R1
0.50
R2
0.52
R3
0.55

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
0.5311 – 0.7189
±15.03% from 0.625, made 2026-09-25 · resolves 2026-10-02
STRONG SELL
from 19 indicators
78.6% of our last 30385 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsBUY
4 buy · 0 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)25.10BUY
Stochastic %K (14)3.03BUY
CCI (20)-246.33BUY
Williams %R (14)-96.97BUY
MACD (12,26,9)-0.03SELL
ROC (10)-33.33SELL
Momentum (10)-0.22SELL
EMA (10)0.59SELL
SMA (10)0.63SELL
EMA (20)0.65SELL
SMA (20)0.67SELL
EMA (30)0.67SELL
SMA (30)0.71SELL
EMA (50)0.71SELL
SMA (50)0.70SELL
EMA (100)0.79SELL
SMA (100)0.78SELL
EMA (200)0.94SELL
SMA (200)0.98SELL

About IRIX

Healthcare · Medical Devices

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

iridex.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Verdict

🔴 AVOID

The main driver: lagging the market by 34.7%. Too many signals pointing the wrong way. Wait for the picture to improve before committing capital.

Scores: 1 bullish / 3 bearish

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 43
🕐 1H BEARISH 35
⏱ 15-Min RANGING 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-32.3%
Rate of change (10d)
13.9×
Volume vs its 20-day average
-0.05
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-17 · Asset managers net 895049 (-19081)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.